Literature DB >> 226261

Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.

M D Eaglesome, J N Henry, J D McKnight.   

Abstract

Vaccination, in July and again in either November or December 1976, of 55 pregnant Standardbred mares with a live-virus rhinopneumonitis vaccine attenuated in cell culture failed to protect some mares from infection with equine herpesvirus 1. From 1976-12-08 to 1977-03-08, 33 mares foaled healthy foals, 16 mares foaled dead foals or live foals which died usually within 48 hours and six mares aborted. Gross and histological examinations and virus isolation studies confirmed that equine herpesvirus 1 caused 18 of the 22 neonatal deaths, stillbirths or abortions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226261      PMCID: PMC1789542     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  5 in total

1.  Equine virus abortion in Canada. I. Pathological studies on aborted fetuses.

Authors:  A H CORNER; D MITCHELL; E B MEADS
Journal:  Cornell Vet       Date:  1963-01

2.  Epizootiology of equine viral rhinopneumonitis.

Authors:  E R DOLL; J T BRYANS
Journal:  J Am Vet Med Assoc       Date:  1963-01-01       Impact factor: 1.936

3.  Immunization against viral rhinopneumonitis of horses with live virus propagated in hamsters.

Authors:  E R DOLL
Journal:  J Am Vet Med Assoc       Date:  1961-12-15       Impact factor: 1.936

4.  Paralysis of horses associated with equine herpesvirus 1 infection.

Authors:  T Jackson; J W Kendrick
Journal:  J Am Vet Med Assoc       Date:  1971-04-15       Impact factor: 1.936

5.  On immunity to disease caused by equine herpesvirus 1.

Authors:  J T Bryans
Journal:  J Am Vet Med Assoc       Date:  1969-07-15       Impact factor: 1.936

  5 in total
  1 in total

1.  Criteria for development of animal models of diseases of the reproductive system.

Authors:  L B Corbeil
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.